QGEN
HEALTHCAREQiagen NV
$34.44+0.44 (+1.29%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving QGEN Today?
No stock-specific AI insight has been generated for QGEN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$33.17$57.82
$34.44
Fundamentals
Market Cap$7.1B
P/E Ratio16.9
EPS$2.04
Dividend Yield0.01%
Dividend / Share$0.26
ROE0.1%
Profit Margin0.2%
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding206.1M
QGEN News
25 articles- Qiagen (QGEN) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB TestingYahoo Finance·May 7, 2026
- Qiagen (QGEN) Q1 Earnings and Revenues Lag EstimatesYahoo Finance·May 7, 2026
- Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·May 7, 2026
- QIAGEN Reports Full Results for Q1 2026Yahoo Finance·May 6, 2026
- [Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Yahoo Finance·May 4, 2026
- Qiagen Cuts 2026 Outlook as QuantiFERON Immigration Testing Slumps Despite EPS MatchMarketbeat·May 4, 2026
- How The Qiagen (QGEN) Investment Story Is Shifting As Analysts Rework Their AssumptionsYahoo Finance·May 1, 2026
- Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsightGlobeNewswire Inc.·Apr 29, 2026
- Qiagen NV (QGEN) Q1 2026 Earnings Call Highlights: Navigating Mixed Sales with Strong ProfitabilityYahoo Finance·Apr 29, 2026
- Coursera, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesGlobeNewswire Inc.·Apr 29, 2026
- Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1Yahoo Finance·Apr 29, 2026
- Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesGlobeNewswire Inc.·Apr 29, 2026
- QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlookYahoo Finance·Apr 27, 2026
- Arcus Biosciences (RCUS) Moves 7.8% Higher: Will This Strength Last?Yahoo Finance·Apr 22, 2026
- Qiagen (NYSE:QGEN) Valuation Check After Recent Share Price SwingsYahoo Finance·Apr 18, 2026
- QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026Yahoo Finance·Apr 16, 2026
- How QIAGEN’s (QGEN) Diagnostics Expansion Strengthens Its Takeover AppealYahoo Finance·Apr 16, 2026
- QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx PanelYahoo Finance·Apr 14, 2026
- Tesla upgraded, AppLovin initiated: Wall Street's top analyst callsYahoo Finance·Apr 14, 2026
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, Ford, Lennox International, Netskope, SanDisk, Tesla, and More247 Wall St·Apr 14, 2026
- Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision MedicineGlobeNewswire Inc.·Apr 10, 2026
- Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS InsiderGlobeNewswire Inc.·Apr 3, 2026
- Qiagen (QGEN) Upgraded to Buy by Deutsche Bank After 30% DeclineYahoo Finance·Apr 2, 2026
- Bruker Announces Appointment of Thierry Bernard to its Board of DirectorsYahoo Finance·Apr 1, 2026
All 25 articles loaded
Price Data
Open$34.32
Previous Close$34.00
Day High$34.54
Day Low$34.05
52 Week High$57.82
52 Week Low$33.17
52-Week Range
$33.17$57.82
$34.44
Fundamentals
Market Cap$7.1B
P/E Ratio16.9
EPS$2.04
Dividend Yield0.01%
Dividend / Share$0.26
ROE0.1%
Profit Margin0.2%
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding206.1M
About Qiagen NV
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—